Article Text
PDF
Statistics from Altmetric.com
Background
Updated national guidance1 was issued in October 2023 based on the lessons learnt during COVID-19 in 2020 for the management of children in hospital with viral respiratory tract infections. This includes the application of isolation, segregation, mask wearing and testing for respiratory viruses in the emergency acute unscheduled care pathway. This should ensure that services are maintained, and transmission of respiratory viruses is reduced within the hospital settings.
Updates include
Hierarchy of controls: online supplemental appendix 1.
Definition of aerosol generating procedures (AGPs): online supplemental appendix 2.
Detailed explanation of how to minimise transmission of respiratory viruses: online supplemental appendix 3.
Principles on room ventilation: online supplemental appendix 4.
Children at highest risk of severe infection: online supplemental appendix 5.
Removal of indications and contraindications for high flow nasal cannula oxygen: online supplemental appendix 6.
Treatment of non-hospitalised children at risk of severe disease: online supplemental appendix 7.
Guidance about children presenting with suspected measles.
Supplemental material
Supplemental material
Supplemental material
Supplemental material
Supplemental material
Supplemental material
Supplemental material
Information about the current guideline
Aim: Update recommendations on the management of children in hospital with viral respiratory tract infections are for clinicians to support planning in partnership with local infection prevention control (IPC) teams.
Publication date: 20th Sept 2020
Updated: 24th October 2023
Modified 21st March 2024
Key Stakeholders: Clinicians in the emergency department (ED), paediatric intensive care unit (PICU), high dependency unit (HDU), paediatric wards and acute care settings that see patients with respiratory viruses along with parents and carers.
Key issues
Sustaining robust infection prevention control (IPC) processes during …
Footnotes
X @ProfGRoberts
Contributors JS wrote this guideline review, she is the guarantor, with supervision from Professor GR.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Provenance and peer review Commissioned; externally peer reviewed.
Supplemental material This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.